Julie M. Rivers

Hematology | Oncology
4800 Sand Point Way NE
Seattle, WA 98105

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.

Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.

Journal: Blood advances
Published: September 06, 2024

Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL.

Feasibility and favorable responses after investigational CAR T-cell therapy for relapsed and refractory infant ALL.

Journal: Blood advances
Published: February 20, 2024

Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.

Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disorders.

Journal: Cancer
Published: September 20, 2022

Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative.

Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative.

Journal: British journal of haematology
Published: July 08, 2022

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy.

Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy.

Journal: Blood
Published: May 06, 2019

Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.

Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.

Journal: Transfusion
Published: October 13, 2017
Showing 1-6 of 6

Last Updated: 09/26/2026